Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Laboratories Pakistan | Karachi | Salute | Prodotti farmaceutici | 76,85 Mrd PKR | 24x | 0,04 | 793,59 PKR | 3,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Haleon Pakistan | Karachi | Salute | Prodotti farmaceutici | 69,30 Mrd PKR | 68,8x | 595,22 PKR | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
GlaxoSmithKline Pakistan | Karachi | Salute | Prodotti farmaceutici | 67,58 Mrd PKR | 27x | 0,41 | 210,35 PKR | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Highnoon Labs | Karachi | Salute | Prodotti farmaceutici | 40,58 Mrd PKR | 14,3x | 1,44 | 769,47 PKR | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AGP | Karachi | Salute | Prodotti farmaceutici | 34,41 Mrd PKR | 18,6x | 0,35 | 122,44 PKR | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -18,1% Ribasso | Fai l’upgrade a Pro+ | |
The Searle Company | Karachi | Salute | Prodotti farmaceutici | 31,76 Mrd PKR | -12,4x | -0,03 | 61,09 PKR | -3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,3% Rialzo | Fai l’upgrade a Pro+ | |
Hoechst Pakistan | Karachi | Salute | Prodotti farmaceutici | 19,35 Mrd PKR | 11,3x | 0,03 | 2.219,13 PKR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ferozsons Labs | Karachi | Salute | Prodotti farmaceutici | 12,48 Mrd PKR | 18,3x | 0,12 | 286,50 PKR | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,4% Rialzo | Fai l’upgrade a Pro+ | |
Citi Pharma | Karachi | Salute | Prodotti farmaceutici | 9,21 Mrd PKR | 11,9x | 0,45 | 39,29 PKR | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Macter International | Karachi | Salute | Prodotti farmaceutici | 6,37 Mrd PKR | 14,6x | 138 PKR | 3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Otsuka Pakistan | Karachi | Salute | Prodotti farmaceutici | 1,55 Mrd PKR | -324,9x | -9,75 | 125,21 PKR | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |